LEONI, PIETRO
LEONI, PIETRO
HIGH RATE OF COMPLETE HEMATOLOGICAL RESPONSE IN ELDERLY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY INNOVATIVE SEQUENTIAL USE OF NILOTINIB AND IMATINIB: A GIMEMA CLINICAL TRIAL LAL 1408
2015 Cristina Papayannidis , Alfonso Piciocchi , Antonella Vitale , Simona Soverini , Caterina De Benedittis , Ilaria Iacobucci , Stefania Paolini , Chiara Sartor , Mariachiara Abbenante , Francesco Di Raimondo , Massimiliano Bonifacio , Angelo Michele Carella , Mario Cazzola , Antonio Cuneo , Pietro Leoni , Mario Luppi , Enrica Morra , Giorgina Specchia , Daniele Vallisa , Monica Bocchia , Renato Fanin , Giuseppe Saglio , Loredana Elia , Robin Foà , Michele Cavo , Michele Baccarani , Giovanni Martinelli
Sequential use of first and second generation TKIs are effective on prolonged overall survival in elderly population affected by Ph+ acute lymphoblastic leukemia: the GIMEMA experience
2015 Chiara Sartor, Cristina Papayannidis, Alfonso Piciocchi, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Pier Luigi Lollini, Francesco Di Raimondo, Stefania Paolini, Massimiliano Bonifacio, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Loredana Elia, Robin Foà, Michele Baccarani, Giovanni Martinelli
Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408
2014 Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Francesco D. Raimondo, Stefania Paolini, Massimiliano Bonifacio, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Loredana Elia, Robin Foà, Michele Baccarani
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse.
2012 Cristina Papayannidis, Paola Fazi, Alfonso Piciocchi, Francesco Di Raimondo, Giovanni Pizzolo, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Emanuele Angelucci, Monica Bocchia, Renato Fanin, Giuseppe Saglio, Daniele Vallisa, Sandra De Simone, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Anna Ferrari, Claudia Venturi, Caterina De Benedittis, Nicoletta Testoni, Antonio Curti, Stefania Paolini, Miriam Fogli, Giovanni Martinelli, Michele Baccarani
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| HIGH RATE OF COMPLETE HEMATOLOGICAL RESPONSE IN ELDERLY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY INNOVATIVE SEQUENTIAL USE OF NILOTINIB AND IMATINIB: A GIMEMA CLINICAL TRIAL LAL 1408 | Cristina Papayannidis , Alfonso Piciocchi , Antonella Vitale , Simona Soverini , Caterina De Bene...dittis , Ilaria Iacobucci , Stefania Paolini , Chiara Sartor , Mariachiara Abbenante , Francesco Di Raimondo , Massimiliano Bonifacio , Angelo Michele Carella , Mario Cazzola , Antonio Cuneo , Pietro Leoni , Mario Luppi , Enrica Morra , Giorgina Specchia , Daniele Vallisa , Monica Bocchia , Renato Fanin , Giuseppe Saglio , Loredana Elia , Robin Foà , Michele Cavo , Michele Baccarani , Giovanni Martinelli | 2015-01-01 | HAEMATOLOGICA | - | 1.06 Abstract in rivista | - |
| Sequential use of first and second generation TKIs are effective on prolonged overall survival in elderly population affected by Ph+ acute lymphoblastic leukemia: the GIMEMA experience | Chiara Sartor, Cristina Papayannidis, Alfonso Piciocchi, Antonella Vitale, Ilaria Iacobucci, Simo...na Soverini, Pier Luigi Lollini, Francesco Di Raimondo, Stefania Paolini, Massimiliano Bonifacio, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Loredana Elia, Robin Foà, Michele Baccarani, Giovanni Martinelli | 2015-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408 | Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Antonella Vitale, Ilaria Iacobucci..., Simona Soverini, Francesco D. Raimondo, Stefania Paolini, Massimiliano Bonifacio, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Loredana Elia, Robin Foà, Michele Baccarani | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. | Cristina Papayannidis, Paola Fazi, Alfonso Piciocchi, Francesco Di Raimondo, Giovanni Pizzolo, An...gelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Emanuele Angelucci, Monica Bocchia, Renato Fanin, Giuseppe Saglio, Daniele Vallisa, Sandra De Simone, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Anna Ferrari, Claudia Venturi, Caterina De Benedittis, Nicoletta Testoni, Antonio Curti, Stefania Paolini, Miriam Fogli, Giovanni Martinelli, Michele Baccarani | 2012-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |